These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22984766)

  • 1. [The role of the type-three secretion system of the gram-negative bacteria in regulation of chronic infections].
    Zigangirova NA; Nesterenko LN; Tiganova IG; Kost EA
    Mol Gen Mikrobiol Virusol; 2012; (3):3-13. PubMed ID: 22984766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria.
    Keyser P; Elofsson M; Rosell S; Wolf-Watz H
    J Intern Med; 2008 Jul; 264(1):17-29. PubMed ID: 18393958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmonella T3SSs: successful mission of the secret(ion) agents.
    Moest TP; Méresse S
    Curr Opin Microbiol; 2013 Feb; 16(1):38-44. PubMed ID: 23295139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The type VI secretion system: a multipurpose delivery system with a phage-like machinery.
    Records AR
    Mol Plant Microbe Interact; 2011 Jul; 24(7):751-7. PubMed ID: 21361789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of dangerous goods: type III secretion in enteric pathogens.
    Zaharik ML; Gruenheid S; Perrin AJ; Finlay BB
    Int J Med Microbiol; 2002 Mar; 291(8):593-603. PubMed ID: 12008913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Horizontally transferred genetic elements and their role in pathogenesis of bacterial disease.
    Gyles C; Boerlin P
    Vet Pathol; 2014 Mar; 51(2):328-40. PubMed ID: 24318976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polynucleotide phosphorylase independently controls virulence factor expression levels and export in Yersinia spp.
    Rosenzweig JA; Chromy B; Echeverry A; Yang J; Adkins B; Plano GV; McCutchen-Maloney S; Schesser K
    FEMS Microbiol Lett; 2007 May; 270(2):255-64. PubMed ID: 17391372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type III secretion à la Chlamydia.
    Peters J; Wilson DP; Myers G; Timms P; Bavoil PM
    Trends Microbiol; 2007 Jun; 15(6):241-51. PubMed ID: 17482820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic mutation analysis of two-component signal transduction systems reveals EsrA-EsrB and PhoP-PhoQ as the major virulence regulators in Edwardsiella tarda.
    Lv Y; Xiao J; Liu Q; Wu H; Zhang Y; Wang Q
    Vet Microbiol; 2012 May; 157(1-2):190-9. PubMed ID: 22227416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Type III secretion system of Vibrio parahaemolyticus--a review].
    Yu Y; Wu B; Fang W
    Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):848-52. PubMed ID: 19873746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional domains and motifs of bacterial type III effector proteins and their roles in infection.
    Dean P
    FEMS Microbiol Rev; 2011 Nov; 35(6):1100-25. PubMed ID: 21517912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SseL is a salmonella-specific translocated effector integrated into the SsrB-controlled salmonella pathogenicity island 2 type III secretion system.
    Coombes BK; Lowden MJ; Bishop JL; Wickham ME; Brown NF; Duong N; Osborne S; Gal-Mor O; Finlay BB
    Infect Immun; 2007 Feb; 75(2):574-80. PubMed ID: 17158898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell individuality: the bistable gene expression of the type III secretion system in Dickeya dadantii 3937.
    Zeng Q; Laiosa MD; Steeber DA; Biddle EM; Peng Q; Yang CH
    Mol Plant Microbe Interact; 2012 Jan; 25(1):37-47. PubMed ID: 22150074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brucellosis and type IV secretion.
    de Jong MF; Tsolis RM
    Future Microbiol; 2012 Jan; 7(1):47-58. PubMed ID: 22191446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial effector interplay: a new way to view effector function.
    Shames SR; Finlay BB
    Trends Microbiol; 2012 May; 20(5):214-9. PubMed ID: 22425230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The choice of the targets and the search for their inhibitors by means of computer simulation for the development of innovative preparations to treat of chronic bacterial infections].
    Kariagina AS; Zigangirova NA; Grishin AV; Davydova DIu; Krivozubov MS; Kirsanov DD; Zaiakin ES
    Vestn Ross Akad Med Nauk; 2011; (10):22-8. PubMed ID: 22168035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular determinants in regulating Pseudomonas aeruginosa type III secretion system--a review].
    Luo Q; Jin S
    Wei Sheng Wu Xue Bao; 2008 Oct; 48(10):1413-7. PubMed ID: 19160828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression by Lawsonia intracellularis of type III secretion system components during infection.
    Alberdi MP; Watson E; McAllister GE; Harris JD; Paxton EA; Thomson JR; Smith DG
    Vet Microbiol; 2009 Nov; 139(3-4):298-303. PubMed ID: 19589649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antigens and virulence factors of Salmonella enterica serovar Typhi in its pathogenesis.
    Kaur J; Jain SK
    Microbiol Res; 2012 Apr; 167(4):199-210. PubMed ID: 21945101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yersinia's stratagem: targeting innate and adaptive immune defense.
    Heesemann J; Sing A; Trülzsch K
    Curr Opin Microbiol; 2006 Feb; 9(1):55-61. PubMed ID: 16413818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.